Journal
ALZHEIMERS RESEARCH & THERAPY
Volume 14, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s13195-022-01087-4
Keywords
Alzheimer's dementia; Heart failure; Cognitive impairment; Neurofilament light chain; Phosphorylated tau protein; Renal function; Age
Categories
Funding
- Open Access Publication Fund of the University of Wuerzburg
- Bundesministerium fur Bildung und Forschung through the Comprehensive Heart Failure Center, habilitation grant [01EO1004, 01EO1504]
- Comprehensive Heart Failure Center [413657723]
- Interdisciplinary Center of Clinical Research Wurzburg
- Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [453989101]
Ask authors/readers for more resources
This study found that serum levels of pTau and NfL are strongly influenced by age-dependent renal and cardiac dysfunction. These findings suggest the need for longitudinal examinations and consideration of frequent comorbidities when using neuronal serum biomarkers.
Background Chronic heart failure (HF) is known to increase the risk of developing Alzheimer's dementia significantly. Thus, detecting and preventing mild cognitive impairment, which is common in patients with HF, is of great importance. Serum biomarkers are increasingly used in neurological disorders for diagnostics, monitoring, and prognostication of disease course. It remains unclear if neuronal biomarkers may help detect cognitive impairment in this high-risk population. Also, the influence of chronic HF and concomitant renal dysfunction on these biomarkers is not well understood. Methods Within the monocentric Cognition.Matters-HF study, we quantified the serum levels of phosphorylated tau protein 181 (pTau) and neurofilament light chain (NfL) of 146 extensively phenotyped chronic heart failure patients (aged 32 to 85 years; 15.1% women) using ultrasensitive bead-based single-molecule immunoassays. The clinical work-up included advanced cognitive testing and cerebral magnetic resonance imaging (MRI). Results Serum concentrations of NfL ranged from 5.4 to 215.0 pg/ml (median 26.4 pg/ml) and of pTau from 0.51 to 9.22 pg/ml (median 1.57 pg/ml). We detected mild cognitive impairment (i.e., T-score < 40 in at least one cognitive domain) in 60% of heart failure patients. pTau (p = 0.014), but not NfL, was elevated in this group. Both NfL (rho = - 0.21; p = 0.013) and pTau (rho = - 0.25; p = 0.002) related to the cognitive domain visual/verbal memory, as well as white matter hyperintensity volume and cerebral and hippocampal atrophy. In multivariable analysis, both biomarkers were independently influenced by age (T = 4.6 for pTau; T = 5.9 for NfL) and glomerular filtration rate (T = - 2.4 for pTau; T = - 3.4 for NfL). Markers of chronic heart failure, left atrial volume index (T = 4.6) and NT-proBNP (T = 2.8), were further cardiological determinants of pTau and NfL, respectively. In addition, pTau was also strongly affected by serum creatine kinase levels (T = 6.5) and ferritin (T = - 3.1). Conclusions pTau and NfL serum levels are strongly influenced by age-dependent renal and cardiac dysfunction. These findings point towards the need for longitudinal examinations and consideration of frequent comorbidities when using neuronal serum biomarkers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available